How severe is CVE-2026-21974?

CVE-2026-21974 has a CVSS 3.x base score of 5.3, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.

Is CVE-2026-21974 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (12th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2026-21974?

CVE-2026-21974 affects Oracle Life Sciences Central Designer. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2026-21974?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2026-21974 have an EU (EUVD) identifier?

Yes. CVE-2026-21974 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-3538.

When was CVE-2026-21974 published?

CVE-2026-21974 was published on 2026-01-20 and last updated on 2026-06-17.

CVE-2026-21974

CVE-2026-21974 is a medium-severity vulnerability in Oracle Life Sciences Central Designer with a CVSS 3.x base score of 5.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-200.

Key facts

Severity: Medium (CVSS 3.x base score 5.3)
EPSS exploit prediction: 0% (12th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2026-3538
Weakness: CWE-200
Affected product: Oracle Life Sciences Central Designer
Published: 2026-01-20
Last modified: 2026-06-17

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

Frequently asked questions

What is CVE-2026-21974?: Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
How severe is CVE-2026-21974?: CVE-2026-21974 has a CVSS 3.x base score of 5.3, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.
Is CVE-2026-21974 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (12th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-21974?: CVE-2026-21974 affects Oracle Life Sciences Central Designer. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-21974?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2026-21974 have an EU (EUVD) identifier?: Yes. CVE-2026-21974 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-3538.
When was CVE-2026-21974 published?: CVE-2026-21974 was published on 2026-01-20 and last updated on 2026-06-17.

References

https://www.oracle.com/security-alerts/cpujan2026.html

Affected products (1)

cpe:2.3:a:oracle:life_sciences_central_designer:7.0.1.0:*:*:*:*:*:*:*

More vulnerabilities in Oracle Life Sciences Central Designer

CVE-2026-21970 — Medium (CVSS 6.5): Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component:…
CVE-2026-21923 — Medium (CVSS 6.5): Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component:…

All CVEs affecting Oracle Life Sciences Central Designer →

Other CWE-200 (Exposure of Sensitive Information to an Unauthorized Actor) vulnerabilities

CVE-2026-27604 — Critical (CVSS 10.0): FOSSBilling is a free, open-source billing and client management system. Starting in version 0.5.4 and prior to version…
CVE-2026-40965 — Critical (CVSS 10.0): Cloud Foundry UAA versions v76.12.0 through v78.12.0 are vulnerable to a private key exposure. The server contains a…
CVE-2026-42826 — Critical (CVSS 10.0): Exposure of sensitive information to an unauthorized actor in Azure DevOps allows an unauthorized attacker to disclose…
CVE-2025-29270 — Critical (CVSS 10.0): Incorrect access control in the realtime.cgi endpoint of Deep Sea Electronics devices DSE855 v1.1.0 to v1.1.26 allows…
CVE-2025-61481 — Critical (CVSS 10.0): An issue in MikroTik RouterOS v.7.14.2 and SwOS v.2.18 exposes the WebFig management interface over cleartext HTTP by…
CVE-2025-53624 — Critical (CVSS 10.0): The Docusaurus gists plugin adds a page to your Docusaurus instance, displaying all public gists of a GitHub user.…

Browse all CWE-200 (Exposure of Sensitive Information to an Unauthorized Actor) vulnerabilities →